William Plovanic
Stock Analyst at Canaccord Genuity
(4.08)
# 595
Out of 4,745 analysts
140
Total ratings
53.66%
Success rate
11.38%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $92 → $101 | $92.84 | +8.79% | 3 | Jan 10, 2025 | |
| NARI Inari Medical | Downgrades: Hold | $74 → $80 | $79.74 | +0.33% | 15 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $269 → $304 | $280.35 | +8.44% | 3 | Dec 9, 2024 | |
| NVRO Nevro | Maintains: Hold | $7 → $4 | $5.16 | -22.48% | 11 | Dec 9, 2024 | |
| IRTC iRhythm Technologies | Maintains: Buy | $125 → $152 | $110.65 | +37.37% | 9 | Dec 9, 2024 | |
| DXCM DexCom | Maintains: Buy | $89 → $99 | $88.75 | +11.55% | 4 | Dec 9, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $17 → $22 | $17.77 | +23.80% | 6 | Dec 9, 2024 | |
| CBLL CeriBell | Maintains: Buy | $31 → $33 | $22.96 | +43.73% | 3 | Dec 9, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $98 → $101 | $101.94 | -0.92% | 9 | Dec 9, 2024 | |
| ATRC AtriCure | Maintains: Buy | $53 → $61 | $40.58 | +50.32% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $63 → $68 | $68.99 | -1.43% | 24 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $104 | $60.82 | +71.00% | 4 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $5.18 | +112.36% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $56 | $36.50 | +53.42% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $10.03 | +49.55% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $12.19 | -1.56% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $120 → $115 | $110.81 | +3.78% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $3 | $2.44 | +22.95% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $274.06 | +3.63% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $11.01 | +127.07% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $6.11 | +96.40% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $104.64 | -33.10% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $24.45 | +96.32% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $6.25 | +252.00% | 3 | Jul 25, 2023 |
Globus Medical
Jan 10, 2025
Maintains: Buy
Price Target: $92 → $101
Current: $92.84
Upside: +8.79%
Inari Medical
Jan 7, 2025
Downgrades: Hold
Price Target: $74 → $80
Current: $79.74
Upside: +0.33%
Insulet
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $280.35
Upside: +8.44%
Nevro
Dec 9, 2024
Maintains: Hold
Price Target: $7 → $4
Current: $5.16
Upside: -22.48%
iRhythm Technologies
Dec 9, 2024
Maintains: Buy
Price Target: $125 → $152
Current: $110.65
Upside: +37.37%
DexCom
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $99
Current: $88.75
Upside: +11.55%
CVRx, Inc.
Dec 9, 2024
Maintains: Buy
Price Target: $17 → $22
Current: $17.77
Upside: +23.80%
CeriBell
Dec 9, 2024
Maintains: Buy
Price Target: $31 → $33
Current: $22.96
Upside: +43.73%
Boston Scientific
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $101.94
Upside: -0.92%
AtriCure
Dec 9, 2024
Maintains: Buy
Price Target: $53 → $61
Current: $40.58
Upside: +50.32%
Dec 5, 2024
Maintains: Hold
Price Target: $63 → $68
Current: $68.99
Upside: -1.43%
Nov 20, 2024
Maintains: Buy
Price Target: $109 → $104
Current: $60.82
Upside: +71.00%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $11
Current: $5.18
Upside: +112.36%
Nov 7, 2024
Maintains: Buy
Price Target: $57 → $56
Current: $36.50
Upside: +53.42%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $10.03
Upside: +49.55%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $12.19
Upside: -1.56%
Sep 10, 2024
Maintains: Hold
Price Target: $120 → $115
Current: $110.81
Upside: +3.78%
Aug 13, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $2.44
Upside: +22.95%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $274.06
Upside: +3.63%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $11.01
Upside: +127.07%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $6.11
Upside: +96.40%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $104.64
Upside: -33.10%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $24.45
Upside: +96.32%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $6.25
Upside: +252.00%